These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16296781)

  • 1. Strategies for DNA vaccine delivery.
    Alpar HO; Papanicolaou I; Bramwell VW
    Expert Opin Drug Deliv; 2005 Sep; 2(5):829-42. PubMed ID: 16296781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization and delivery of plasmid DNA for vaccination.
    Jechlinger W
    Expert Rev Vaccines; 2006 Dec; 5(6):803-25. PubMed ID: 17184219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine delivery methods using viral vectors.
    Bråve A; Ljungberg K; Wahren B; Liu MA
    Mol Pharm; 2007; 4(1):18-32. PubMed ID: 17274663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid DNA and viral vector-based vaccines for the treatment of cancer.
    Anderson RJ; Schneider J
    Vaccine; 2007 Sep; 25 Suppl 2():B24-34. PubMed ID: 17698262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic vehicles for DNA vaccination.
    van den Berg JH; Nuijen B; Schumacher TN; Haanen JB; Storm G; Beijnen JH; Hennink WE
    J Drug Target; 2010 Jan; 18(1):1-14. PubMed ID: 19814658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-sized vaccine delivery systems.
    Scheerlinck JP; Greenwood DL
    Drug Discov Today; 2008 Oct; 13(19-20):882-7. PubMed ID: 18656548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid maintenance systems suitable for GMO-based bacterial vaccines.
    Spreng S; Viret JF
    Vaccine; 2005 Mar; 23(17-18):2060-5. PubMed ID: 15755571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
    Alpar HO; Somavarapu S; Atuah KN; Bramwell VW
    Adv Drug Deliv Rev; 2005 Jan; 57(3):411-30. PubMed ID: 15560949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal delivery of protein and DNA vaccines.
    Dean HJ
    Expert Opin Drug Deliv; 2005 Mar; 2(2):227-36. PubMed ID: 16296750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells.
    Jilek S; Merkle HP; Walter E
    Adv Drug Deliv Rev; 2005 Jan; 57(3):377-90. PubMed ID: 15560947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA vaccines: vector design, delivery, and antigen presentation.
    Feltquate DM
    J Cell Biochem Suppl; 1998; 30-31():304-11. PubMed ID: 9893284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccines.
    Ongkudon CM; Ho J; Danquah MK
    Crit Rev Biotechnol; 2011 Mar; 31(1):32-52. PubMed ID: 20879832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep.
    Babiuk S; Tsang C; van Drunen Littel-van den Hurk S; Babiuk LA; Griebel PJ
    Bioelectrochemistry; 2007 May; 70(2):269-74. PubMed ID: 17118714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccines and their application against parasites--promise, limitations and potential solutions.
    Smooker PM; Rainczuk A; Kennedy N; Spithill TW
    Biotechnol Annu Rev; 2004; 10():189-236. PubMed ID: 15504707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA vaccines for biodefence.
    Garmory HS; Perkins SD; Phillpotts RJ; Titball RW
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficiency of a novel delivery system (PEI600-Tat) in development of potent DNA vaccine using HPV16 E7 as a model antigen.
    Bolhassani A; Ghasemi N; Servis C; Taghikhani M; Rafati S
    Drug Deliv; 2009 May; 16(4):196-204. PubMed ID: 19514980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes as delivery systems for nasal vaccination: strategies and outcomes.
    Heurtault B; Frisch B; Pons F
    Expert Opin Drug Deliv; 2010 Jul; 7(7):829-44. PubMed ID: 20459361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in mucosal delivery of pDNA vaccines.
    Barnes AG; Barnfield C; Brew R; Klavinskis LS
    Curr Opin Mol Ther; 2000 Feb; 2(1):87-93. PubMed ID: 11249656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical adjuvants for plasmid DNA vaccines.
    Greenland JR; Letvin NL
    Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.